KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Interest Coverage Ratio (2023 - 2025)

Biocryst Pharmaceuticals' Interest Coverage Ratio history spans 8 years, with the latest figure at 18.42 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 10090.73% year-over-year to 18.42; the TTM value through Dec 2025 reached 4.32, up 16848.58%, while the annual FY2025 figure was 4.32, 16848.58% up from the prior year.
  • Interest Coverage Ratio reached 18.42 in Q4 2025 per BCRX's latest filing, up from 1.51 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 18.42 in Q4 2025 to a low of 0.78 in Q4 2023.
  • Average Interest Coverage Ratio over 3 years is 2.37, with a median of 0.35 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: skyrocketed 76.37% in 2024, then surged 10090.73% in 2025.
  • A 3-year view of Interest Coverage Ratio shows it stood at 0.78 in 2023, then soared by 76.37% to 0.18 in 2024, then surged by 10090.73% to 18.42 in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Interest Coverage Ratio are 18.42 (Q4 2025), 1.51 (Q3 2025), and 1.38 (Q2 2025).